首页 > 最新文献

Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery最新文献

英文 中文
Intralesional corticosteroid in the treatment of periorbital Kimura disease: a case report. 病灶内皮质类固醇治疗眶周木村病1例。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-01 DOI: 10.1080/01676830.2025.2518561
Mashael Alkhayyal, Atheer Alhumud, Jawaher Alwatban

Kimura disease (KD) is a rare chronic inflammatory disorder characterized by benign subcutaneous masses primarily in the head and neck region, often accompanied by regional lymphadenopathy, elevated serum immunoglobulin E (IgE) levels, and peripheral eosinophilia. The management of peri-orbital KD poses a challenge due to its infiltrative nature and potential aesthetic concerns. We present a case of a 19-year-old male with nephrotic syndrome who developed a painless, slowly enlarging mass in the left peri-orbital region. Imaging showed a well-defined soft tissue mass with no intraorbital extension. Histopathology confirmed KD. Following incisional biopsy, the patient received monthly intralesional corticosteroid injections (2 ml of triamcinolone acetonide, 20 mg/ml) for six months. There was a significant reduction in mass size, with no recurrence over a one-year follow-up period. This case highlights the effectiveness of intralesional corticosteroids as a minimally invasive treatment option for peri-orbital KD, particularly when complete surgical resection is not feasible.

木村病(KD)是一种罕见的慢性炎症性疾病,主要表现为头颈部良性皮下肿块,常伴有局部淋巴结病变、血清免疫球蛋白E (IgE)水平升高和周围嗜酸性粒细胞增多。由于其浸润性和潜在的美学问题,眶周KD的管理提出了挑战。我们提出一个19岁的男性肾病综合征谁发展无痛,缓慢扩大肿块在左眶周区域。影像学显示一界限分明的软组织肿块,无眶内延伸。组织病理学证实为KD。切口活检后,患者每月接受病灶内皮质类固醇注射(曲安奈德2ml, 20mg /ml),持续6个月。肿块大小明显减小,1年随访期间无复发。本病例强调了病灶内皮质类固醇作为眶周KD的微创治疗选择的有效性,特别是在完全手术切除不可行的情况下。
{"title":"Intralesional corticosteroid in the treatment of periorbital Kimura disease: a case report.","authors":"Mashael Alkhayyal, Atheer Alhumud, Jawaher Alwatban","doi":"10.1080/01676830.2025.2518561","DOIUrl":"10.1080/01676830.2025.2518561","url":null,"abstract":"<p><p>Kimura disease (KD) is a rare chronic inflammatory disorder characterized by benign subcutaneous masses primarily in the head and neck region, often accompanied by regional lymphadenopathy, elevated serum immunoglobulin E (IgE) levels, and peripheral eosinophilia. The management of peri-orbital KD poses a challenge due to its infiltrative nature and potential aesthetic concerns. We present a case of a 19-year-old male with nephrotic syndrome who developed a painless, slowly enlarging mass in the left peri-orbital region. Imaging showed a well-defined soft tissue mass with no intraorbital extension. Histopathology confirmed KD. Following incisional biopsy, the patient received monthly intralesional corticosteroid injections (2 ml of triamcinolone acetonide, 20 mg/ml) for six months. There was a significant reduction in mass size, with no recurrence over a one-year follow-up period. This case highlights the effectiveness of intralesional corticosteroids as a minimally invasive treatment option for peri-orbital KD, particularly when complete surgical resection is not feasible.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"864-868"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DeepSeekTM and lacrimal drainage disorders: hype or is it performing better than ChatGPTTM? DeepSeekTM和泪道引流障碍:炒作还是比ChatGPTTM表现更好?
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-05-08 DOI: 10.1080/01676830.2025.2501656
Mohammad Javed Ali

Purpose: This study aimed to report the performance of the large language model DeepSeekTM (DeepSeek TM, Hangzhou, China) and perform a head-to-head comparison with ChatGPTTM (OpenAI, San Francisco, USA) in the context of lacrimal drainage disorders.

Methods: Questions and statements were used to construct prompts to include common and uncommon aspects of lacrimal drainage disorders. Prompts avoided covering new knowledge beyond February 2024. Prompts were presented at least twice to the latest versions of DeepSeekTM and ChatGPTTM [Accessed February 15-18, 2025]. A set of assessed prompts for ChatGPTTM from 2023 (ChatGPT-2023) was utilized in this study. The responses of DeepSeekTM and ChatGPTTM were analyzed for evidence-based content, updated knowledge, specific responses, speed, and factual inaccuracies. The responses of the current ChatGPTTM were also compared with those of 2023 to assess the improvement of the artificial intelligence chatbot. Three lacrimal surgeons graded the responses into three categories: correct, partially correct, and factually incorrect. They also compared the overall quality of the response between DeepSeekTM and ChatGPTTM based on the overall content, organization, and clarity of the answers.

Results: 25 prompts were presented to the latest versions [February 2025] of DeepSeekTM and ChatGPTTM. There was no significant difference in the speed of response. The agreement among the three observers was high (96%) in grading the responses. In terms of the accuracy of the responses, both AI models were similar. DeepSeek's responses were graded as correct in 60% (15/25), partially correct in 36% (9/25), and factually incorrect in 4% (1/25). ChatGPT-2025 responses were graded as correct in 56% (14/25), partially correct in 40% (10/25), and factually incorrect in 4% (1/25). Compared to 2023, ChatGPT-2025 gave responses which were more specific, more accurate, less generic with lesser recycling of phrases. When confronted with inaccuracies, both admitted and corrected the mistakes in subsequent responses. Both the AI models demonstrated the capability of challenging incorrect prompts and premises.

Conclusion: DeepSeekTM was not superior but comparable to ChatGPTTM in the context of lacrimal drainage disorders. Each had unique advantages and could complement each other. They need to be specifically trained and re-trained for individual medical subspecialties.

目的:本研究旨在报道大型语言模型DeepSeekTM (DeepSeek TM,杭州,中国)在泪道引流障碍中的表现,并与ChatGPTTM (OpenAI,旧金山,美国)进行直接比较。方法:采用提问和陈述的方法构建提示,包括泪道引流障碍的常见和不常见方面。提示避免涵盖2024年2月以后的新知识。在DeepSeekTM和ChatGPTTM的最新版本中,至少出现了两次提示[访问日期:2025年2月15日至18日]。本研究使用了一套2023年的ChatGPTTM评估提示(ChatGPT-2023)。对DeepSeekTM和ChatGPTTM的响应进行了基于证据的内容、最新知识、具体响应、速度和事实不准确性的分析。将当前ChatGPTTM的响应与2023年的响应进行比较,以评估人工智能聊天机器人的改进。三位泪道外科医生将回答分为三类:正确、部分正确和完全错误。他们还根据答案的整体内容、组织和清晰度,比较了DeepSeekTM和ChatGPTTM的总体回答质量。结果:在DeepSeekTM和ChatGPTTM的最新版本[2025年2月]中呈现了25个提示。两组在反应速度上无显著差异。三位观察员对评分的一致性很高(96%)。在回答的准确性方面,两种人工智能模型是相似的。DeepSeek的回答有60%(15/25)是正确的,36%(9/25)是部分正确的,4%(1/25)是完全错误的。ChatGPT-2025的回答有56%(14/25)为正确,40%(10/25)为部分正确,4%(1/25)为完全错误。与2023年相比,ChatGPT-2025给出的回答更具体、更准确、不那么笼统,短语的重复使用也更少。当遇到不准确的地方时,他们都承认并在随后的回答中纠正错误。这两个人工智能模型都展示了挑战错误提示和前提的能力。结论:在泪道引流障碍的治疗中,DeepSeekTM不优于ChatGPTTM,但与ChatGPTTM相当。每一个都有其独特的优势,可以相互补充。他们需要接受个别医学专科的专门培训和再培训。
{"title":"DeepSeek<sup>TM</sup> and lacrimal drainage disorders: hype or is it performing better than ChatGPT<sup>TM</sup>?","authors":"Mohammad Javed Ali","doi":"10.1080/01676830.2025.2501656","DOIUrl":"10.1080/01676830.2025.2501656","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to report the performance of the large language model DeepSeek<sup>TM</sup> (DeepSeek TM, Hangzhou, China) and perform a head-to-head comparison with ChatGPT<sup>TM</sup> (OpenAI, San Francisco, USA) in the context of lacrimal drainage disorders.</p><p><strong>Methods: </strong>Questions and statements were used to construct prompts to include common and uncommon aspects of lacrimal drainage disorders. Prompts avoided covering new knowledge beyond February 2024. Prompts were presented at least twice to the latest versions of DeepSeek<sup>TM</sup> and ChatGPT<sup>TM</sup> [Accessed February 15-18, 2025]. A set of assessed prompts for ChatGPT<sup>TM</sup> from 2023 (ChatGPT-2023) was utilized in this study. The responses of DeepSeek<sup>TM</sup> and ChatGPT<sup>TM</sup> were analyzed for evidence-based content, updated knowledge, specific responses, speed, and factual inaccuracies. The responses of the current ChatGPT<sup>TM</sup> were also compared with those of 2023 to assess the improvement of the artificial intelligence chatbot. Three lacrimal surgeons graded the responses into three categories: correct, partially correct, and factually incorrect. They also compared the overall quality of the response between DeepSeek<sup>TM</sup> and ChatGPT<sup>TM</sup> based on the overall content, organization, and clarity of the answers.</p><p><strong>Results: </strong>25 prompts were presented to the latest versions [February 2025] of DeepSeek<sup>TM</sup> and ChatGPT<sup>TM</sup>. There was no significant difference in the speed of response. The agreement among the three observers was high (96%) in grading the responses. In terms of the accuracy of the responses, both AI models were similar. DeepSeek's responses were graded as correct in 60% (15/25), partially correct in 36% (9/25), and factually incorrect in 4% (1/25). ChatGPT-2025 responses were graded as correct in 56% (14/25), partially correct in 40% (10/25), and factually incorrect in 4% (1/25). Compared to 2023, ChatGPT-2025 gave responses which were more specific, more accurate, less generic with lesser recycling of phrases. When confronted with inaccuracies, both admitted and corrected the mistakes in subsequent responses. Both the AI models demonstrated the capability of challenging incorrect prompts and premises.</p><p><strong>Conclusion: </strong>DeepSeek<sup>TM</sup> was not superior but comparable to ChatGPT<sup>TM</sup> in the context of lacrimal drainage disorders. Each had unique advantages and could complement each other. They need to be specifically trained and re-trained for individual medical subspecialties.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"736-742"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144018318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral sino-nasal-orbital fungal necrosis associated with hemophagocytic lymphohistiocytosis. 双侧鼻眶真菌坏死伴噬血细胞性淋巴组织细胞增多症。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-06-02 DOI: 10.1080/01676830.2025.2509238
Aline Ramos da Silva, Antonio Augusto Cruz, Fernando Chahud, Persio Roxo-Junior

Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition caused by hyperactive T cells and macrophages, which release pro-inflammatory cytokines. The diagnosis is based on eight criteria: fever, bi- or tri-lineage cytopenias, splenomegaly, hyperferritinemia, hypofibrinogenemia or hypertriglyceridemia, elevated soluble CD25 levels, low or absent NK cell cytotoxicity, and hemophagocytosis. We report a 1-month-old male infant who was being treated in the pediatric intensive care unit for neonatal infection when he developed six of the eight criteria for HLH, along with bilateral upper eyelid edema that progressed to bilateral sino-nasal-orbital necrosis. MRI revealed a large area of contrast loss involving the nose and both orbits, consistent with fungal necrosis. Biopsy and culture identified Aspergillus fumigatus. Despite antifungal and immunosuppressive treatment, the infant died one week later. We emphasize the need to consider opportunistic fungal infections in HLH patients, particularly when there is rapid and severe clinical deterioration.

噬血细胞淋巴组织细胞病(HLH)是一种罕见的高炎症性疾病,由T细胞和巨噬细胞过度活跃引起,巨噬细胞释放促炎细胞因子。诊断基于8个标准:发热、双系或三系细胞减少症、脾肿大、高铁蛋白血症、低纤维蛋白原血症或高甘油三酯血症、可溶性CD25水平升高、NK细胞毒性低或不存在以及噬血细胞症。我们报告了一个1个月大的男婴,他在儿科重症监护室接受新生儿感染治疗时,出现了HLH的8项标准中的6项,并伴有双侧上眼睑水肿,进展为双侧鼻眶坏死。MRI显示鼻部及双眼眶大面积造影剂丧失,与真菌性坏死相符。活检和培养鉴定为烟曲霉。尽管进行了抗真菌和免疫抑制治疗,婴儿还是在一周后死亡。我们强调需要考虑机会性真菌感染的HLH患者,特别是当有快速和严重的临床恶化。
{"title":"Bilateral sino-nasal-orbital fungal necrosis associated with hemophagocytic lymphohistiocytosis.","authors":"Aline Ramos da Silva, Antonio Augusto Cruz, Fernando Chahud, Persio Roxo-Junior","doi":"10.1080/01676830.2025.2509238","DOIUrl":"10.1080/01676830.2025.2509238","url":null,"abstract":"<p><p>Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition caused by hyperactive T cells and macrophages, which release pro-inflammatory cytokines. The diagnosis is based on eight criteria: fever, bi- or tri-lineage cytopenias, splenomegaly, hyperferritinemia, hypofibrinogenemia or hypertriglyceridemia, elevated soluble CD25 levels, low or absent NK cell cytotoxicity, and hemophagocytosis. We report a 1-month-old male infant who was being treated in the pediatric intensive care unit for neonatal infection when he developed six of the eight criteria for HLH, along with bilateral upper eyelid edema that progressed to bilateral sino-nasal-orbital necrosis. MRI revealed a large area of contrast loss involving the nose and both orbits, consistent with fungal necrosis. Biopsy and culture identified <i>Aspergillus fumigatus</i>. Despite antifungal and immunosuppressive treatment, the infant died one week later. We emphasize the need to consider opportunistic fungal infections in HLH patients, particularly when there is rapid and severe clinical deterioration.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"827-830"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep learning model for differentiating thyroid eye disease and orbital myositis on computed tomography (CT) imaging. 基于CT影像鉴别甲状腺眼病和眶肌炎的深度学习模型。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-06-03 DOI: 10.1080/01676830.2025.2510587
Sierra K Ha, Lisa Y Lin, Min Shi, Mengyu Wang, Ji Yun Han, Nahyoung Grace Lee

Purpose: To develop a deep learning model using orbital computed tomography (CT) imaging to accurately distinguish thyroid eye disease (TED) and orbital myositis, two conditions with overlapping clinical presentations.

Methods: Retrospective, single-center cohort study spanning 12 years including normal controls, TED, and orbital myositis patients with orbital imaging and examination by an oculoplastic surgeon. A deep learning model employing a Visual Geometry Group-16 network was trained on various binary combinations of TED, orbital myositis, and controls using single slices of coronal orbital CT images.

Results: A total of 1628 images from 192 patients (110 TED, 51 orbital myositis, 31 controls) were included. The primary model comparing orbital myositis and TED had accuracy of 98.4% and area under the receiver operating characteristic curve (AUC) of 0.999. In detecting orbital myositis, it had a sensitivity, specificity, and F1 score of 0.964, 0.994, and 0.984, respectively.

Conclusions: Deep learning models can differentiate TED and orbital myositis based on a single, coronal orbital CT image with high accuracy. Their ability to distinguish these conditions based not only on extraocular muscle enlargement but also other salient features suggests potential applications in diagnostics and treatment beyond these conditions.

目的:建立一种利用眼眶计算机断层扫描(CT)成像的深度学习模型,以准确区分甲状腺眼病(TED)和眼眶肌炎这两种临床表现重叠的疾病。方法:回顾性、单中心队列研究,研究时间跨度为12年,包括正常对照、TED和眼眶肌炎患者,并由眼科医生进行眼眶成像和检查。采用视觉几何组-16网络的深度学习模型在使用单张冠状眶CT图像的TED、眶肌炎和对照组的各种二元组合上进行训练。结果:共纳入192例患者的1628张图像(TED 110例,眼眶肌炎51例,对照组31例)。眼眶肌炎与TED对比的初步模型准确率为98.4%,受者工作特征曲线下面积(AUC)为0.999。检测眼眶肌炎的敏感性、特异性和F1评分分别为0.964、0.994和0.984。结论:深度学习模型可以根据单张眶冠状面CT图像准确区分TED和眶肌炎。他们区分这些疾病的能力不仅基于眼外肌的扩大,而且还基于其他显著特征,这表明在诊断和治疗这些疾病之外的潜在应用。
{"title":"Deep learning model for differentiating thyroid eye disease and orbital myositis on computed tomography (CT) imaging.","authors":"Sierra K Ha, Lisa Y Lin, Min Shi, Mengyu Wang, Ji Yun Han, Nahyoung Grace Lee","doi":"10.1080/01676830.2025.2510587","DOIUrl":"10.1080/01676830.2025.2510587","url":null,"abstract":"<p><strong>Purpose: </strong>To develop a deep learning model using orbital computed tomography (CT) imaging to accurately distinguish thyroid eye disease (TED) and orbital myositis, two conditions with overlapping clinical presentations.</p><p><strong>Methods: </strong>Retrospective, single-center cohort study spanning 12 years including normal controls, TED, and orbital myositis patients with orbital imaging and examination by an oculoplastic surgeon. A deep learning model employing a Visual Geometry Group-16 network was trained on various binary combinations of TED, orbital myositis, and controls using single slices of coronal orbital CT images.</p><p><strong>Results: </strong>A total of 1628 images from 192 patients (110 TED, 51 orbital myositis, 31 controls) were included. The primary model comparing orbital myositis and TED had accuracy of 98.4% and area under the receiver operating characteristic curve (AUC) of 0.999. In detecting orbital myositis, it had a sensitivity, specificity, and F1 score of 0.964, 0.994, and 0.984, respectively.</p><p><strong>Conclusions: </strong>Deep learning models can differentiate TED and orbital myositis based on a single, coronal orbital CT image with high accuracy. Their ability to distinguish these conditions based not only on extraocular muscle enlargement but also other salient features suggests potential applications in diagnostics and treatment beyond these conditions.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"758-766"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144209881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital angioleiomyoma with GJA4 mutation mimicking cavernous venous malformation: a case report and comprehensive review. 眼眶血管平滑肌瘤伴GJA4突变似海绵状静脉畸形1例报告及综合复习。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-18 DOI: 10.1080/01676830.2025.2515594
Marie Callet, Arnault Tauziede-Espariat, Augustin Lecler, Sorin Aldea, Pierre Vincent Jacomet, Olivier Galatoire, Mathieu Veyrat

Orbital angioleiomyomas are rare benign tumors that can mimic orbital cavernous venous malformations (OCVM) due to overlapping radiological and histopathological features. We present the case of a 42-year-old woman with an apical orbital angioleiomyoma incidentally discovered during evaluation for migraines. Magnetic resonance imaging revealed a well-defined, gadolinium-enhancing intraconal mass, initially suggestive of OCVM. Surgical excision was performed via an endonasal endoscopic approach, achieving complete removal without recurrence. Histopathological analysis and molecular testing confirmed the diagnosis, identifying a somatic GJA4 (p.Gly41Cys) mutation.This case highlights the diagnostic challenge of distinguishing orbital angioleiomyomas from OCVM and emphasizes the importance of immunohistochemistry and molecular analysis, particularly GJA4 mutation screening, in achieving diagnostic accuracy. The identification of GJA4 mutations may assist clinicians and pathologists in better characterizing true angioleiomyomas, especially in cases where the distinction between OCVM and the cavernous subtype of angioleiomyoma is histologically ambiguous. Angioleiomyomas may be underrecognized in orbital pathology and could represent a subset of lesions previously classified as OCVM or intracranial meningiomas. A comprehensive, multimodal diagnostic approach is essential for appropriate classification and management of these tumors.

摘要眼眶血管平滑肌瘤是一种罕见的良性肿瘤,其影像学和病理组织学特征重叠,与眼眶海绵状静脉畸形相似。我们提出的情况下,一个42岁的妇女与顶端眼眶血管平滑肌瘤偶然发现在评估偏头痛。磁共振成像显示一界限分明、钆增强的腔内肿块,初步提示OCVM。手术切除通过鼻内窥镜入路进行,完全切除无复发。组织病理学分析和分子检测证实了诊断,鉴定出体细胞GJA4 (p.Gly41Cys)突变。本病例强调了区分眼眶血管平滑肌瘤和OCVM的诊断挑战,并强调了免疫组织化学和分子分析的重要性,特别是GJA4突变筛查,以实现诊断准确性。GJA4突变的鉴定可以帮助临床医生和病理学家更好地表征真正的血管平滑肌瘤,特别是在OCVM和血管平滑肌瘤海绵状亚型之间的区别在组织学上不明确的情况下。血管平滑肌瘤可能在眼眶病理中未被充分认识,并且可能代表以前归类为OCVM或颅内脑膜瘤的病变的一个子集。一个全面的,多模式的诊断方法是必要的适当分类和管理这些肿瘤。
{"title":"Orbital angioleiomyoma with GJA4 mutation mimicking cavernous venous malformation: a case report and comprehensive review.","authors":"Marie Callet, Arnault Tauziede-Espariat, Augustin Lecler, Sorin Aldea, Pierre Vincent Jacomet, Olivier Galatoire, Mathieu Veyrat","doi":"10.1080/01676830.2025.2515594","DOIUrl":"10.1080/01676830.2025.2515594","url":null,"abstract":"<p><p>Orbital angioleiomyomas are rare benign tumors that can mimic orbital cavernous venous malformations (OCVM) due to overlapping radiological and histopathological features. We present the case of a 42-year-old woman with an apical orbital angioleiomyoma incidentally discovered during evaluation for migraines. Magnetic resonance imaging revealed a well-defined, gadolinium-enhancing intraconal mass, initially suggestive of OCVM. Surgical excision was performed via an endonasal endoscopic approach, achieving complete removal without recurrence. Histopathological analysis and molecular testing confirmed the diagnosis, identifying a somatic GJA4 (p.Gly41Cys) mutation.This case highlights the diagnostic challenge of distinguishing orbital angioleiomyomas from OCVM and emphasizes the importance of immunohistochemistry and molecular analysis, particularly GJA4 mutation screening, in achieving diagnostic accuracy. The identification of GJA4 mutations may assist clinicians and pathologists in better characterizing true angioleiomyomas, especially in cases where the distinction between OCVM and the cavernous subtype of angioleiomyoma is histologically ambiguous. Angioleiomyomas may be underrecognized in orbital pathology and could represent a subset of lesions previously classified as OCVM or intracranial meningiomas. A comprehensive, multimodal diagnostic approach is essential for appropriate classification and management of these tumors.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"857-863"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144664081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent radiographic venous attenuation after superior ophthalmic vein thrombosis from pediatric orbital cellulitis. 小儿眼眶蜂窝织炎引起的眼上静脉血栓形成后持续的x线静脉衰减。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-09 DOI: 10.1080/01676830.2025.2526036
Kevin Chung, Justina Varghese, Simeon Lauer

Superior ophthalmic vein thrombosis (SOVT) is a rare and potentially sight threatening condition that arises from infectious, autoimmune, hypercoagulable, or traumatic causes. With timely diagnosis and treatment, the prognosis for visual and functional recovery is good, though permanent functional and visual loss can occur. We report a case of left septic SOVT in a pediatric patient with radiographic evidence of a small caliber ipsilateral superior ophthalmic vein on MR imaging, 2 and 4 months after full clinical recovery. This radiographic appearance of the superior ophthalmic vein after treatment, in a patient with full recovery, has not previously been reported. Recognition of this persistent change in the caliber of the ipsilateral vein is important to avoid radiographic confusion with contralateral venous congestion.

眼上静脉血栓形成(SOVT)是一种罕见且潜在威胁视力的疾病,由感染性、自身免疫性、高凝性或创伤性原因引起。通过及时的诊断和治疗,视力和功能恢复的预后良好,尽管可能发生永久性的功能和视力丧失。我们报告一例小儿左脓毒性SOVT,在完全临床恢复后的2个月和4个月,影像学上显示有小口径同侧眼上静脉。治疗后眼上静脉的x线表现,在完全康复的患者中,以前没有报道过。认识到同侧静脉口径的持续变化对于避免与对侧静脉充血的x线片混淆是很重要的。
{"title":"Persistent radiographic venous attenuation after superior ophthalmic vein thrombosis from pediatric orbital cellulitis.","authors":"Kevin Chung, Justina Varghese, Simeon Lauer","doi":"10.1080/01676830.2025.2526036","DOIUrl":"10.1080/01676830.2025.2526036","url":null,"abstract":"<p><p>Superior ophthalmic vein thrombosis (SOVT) is a rare and potentially sight threatening condition that arises from infectious, autoimmune, hypercoagulable, or traumatic causes. With timely diagnosis and treatment, the prognosis for visual and functional recovery is good, though permanent functional and visual loss can occur. We report a case of left septic SOVT in a pediatric patient with radiographic evidence of a small caliber ipsilateral superior ophthalmic vein on MR imaging, 2 and 4 months after full clinical recovery. This radiographic appearance of the superior ophthalmic vein after treatment, in a patient with full recovery, has not previously been reported. Recognition of this persistent change in the caliber of the ipsilateral vein is important to avoid radiographic confusion with contralateral venous congestion.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"885-888"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implant extrusion after eye removal for endophthalmitis and panophthalmitis. 眼内炎和全眼炎摘除眼球后植入物挤压。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-16 DOI: 10.1080/01676830.2025.2553661
Yousef Sefau, Ernest Chan, Musbah Khalaff, Ahsen Hussain

Purpose: To evaluate the rate of orbital implant extrusion and exposure following enucleation or evisceration in patients with endophthalmitis or panophthalmitis, and to assess the influence of infectious etiology, implant type, and surgical technique on extrusion risk.

Methods: A systematic review was conducted using MEDLINE, CINAHL, Embase, and Scopus for studies published between January 1980 and December 2024. Studies were included if they evaluated implant extrusion or exposure following eye removal surgery in patients diagnosed with endophthalmitis or panophthalmitis. Fourteen retrospective cohort studies met the inclusion criteria.

Results: Extrusion or exposure rates ranged from 0% to 53%. Pseudomonas aeruginosa was the most frequently implicated pathogen. Non-porous implants, especially silicone, were more commonly associated with extrusion, while porous implants, particularly hydroxyapatite, demonstrated lower complication rates. No clear difference was observed between evisceration and enucleation in terms of extrusion risk.

Conclusions: Implant extrusion is a significant postoperative complication in the setting or endophthalmitis or panophthalmitis. Pseudomonas aeruginosa and the use of non-porous implants may increase extrusion risk. The use of porous implants and appropriate prophylactic antibiotics may be associated with lower risk of extrusion. Further prospective studies are required to standardize risk assessment and prevention strategies.

目的:评价眼内炎或全眼炎患者眼球剜出或全眼剜出后眼窝植入物的挤出和暴露率,并评估感染病因、植入物类型和手术技术对眶内植入物挤出风险的影响。方法:采用MEDLINE、CINAHL、Embase和Scopus对1980年1月至2024年12月间发表的研究进行系统评价。如果研究评估了诊断为眼内炎或全眼炎的患者在眼球摘除手术后植入物的挤压或暴露,则纳入研究。14项回顾性队列研究符合纳入标准。结果:挤压或暴露率为0% ~ 53%。铜绿假单胞菌是最常见的病原体。无孔植入物,尤其是硅胶,更常与挤压相关,而多孔植入物,尤其是羟基磷灰石,并发症发生率较低。在挤压风险方面,未观察到内脏摘除和去核之间的明显差异。结论:假体挤压是眼内炎或全眼炎术后的重要并发症。铜绿假单胞菌和使用无孔植入物可能增加挤压风险。使用多孔植入物和适当的预防性抗生素可能与较低的挤压风险有关。需要进一步的前瞻性研究来规范风险评估和预防策略。
{"title":"Implant extrusion after eye removal for endophthalmitis and panophthalmitis.","authors":"Yousef Sefau, Ernest Chan, Musbah Khalaff, Ahsen Hussain","doi":"10.1080/01676830.2025.2553661","DOIUrl":"10.1080/01676830.2025.2553661","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the rate of orbital implant extrusion and exposure following enucleation or evisceration in patients with endophthalmitis or panophthalmitis, and to assess the influence of infectious etiology, implant type, and surgical technique on extrusion risk.</p><p><strong>Methods: </strong>A systematic review was conducted using MEDLINE, CINAHL, Embase, and Scopus for studies published between January 1980 and December 2024. Studies were included if they evaluated implant extrusion or exposure following eye removal surgery in patients diagnosed with endophthalmitis or panophthalmitis. Fourteen retrospective cohort studies met the inclusion criteria.</p><p><strong>Results: </strong>Extrusion or exposure rates ranged from 0% to 53%. Pseudomonas aeruginosa was the most frequently implicated pathogen. Non-porous implants, especially silicone, were more commonly associated with extrusion, while porous implants, particularly hydroxyapatite, demonstrated lower complication rates. No clear difference was observed between evisceration and enucleation in terms of extrusion risk.</p><p><strong>Conclusions: </strong>Implant extrusion is a significant postoperative complication in the setting or endophthalmitis or panophthalmitis. Pseudomonas aeruginosa and the use of non-porous implants may increase extrusion risk. The use of porous implants and appropriate prophylactic antibiotics may be associated with lower risk of extrusion. Further prospective studies are required to standardize risk assessment and prevention strategies.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"906-912"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions for reducing bleeding and swelling in eyelid and periocular surgeries: a systematic review of randomized controlled trials. 减少眼睑和眼周手术出血和肿胀的干预措施:随机对照试验的系统回顾。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-20 DOI: 10.1080/01676830.2025.2581622
Anas Alamoudi, Asim M Albishry, Ahmed N Alnabihi, Waleed T Batais, Abdulaziz Khalid Aldahlawi, Nawaf F Alghamdi, Mohammad Karam, Christian El-Hadad

Purpose: To systematically evaluate evidence-based interventions aimed at reducing postoperative edema and ecchymosis in eyelid and periocular surgery, with the goal of improving patient outcomes and recovery.

Methods: A systematic review of 29 randomized controlled trials (RCTs), involving 2,287 patients undergoing eyelid and periocular surgery, was conducted. A comprehensive search was performed across Embase, MEDLINE, Cochrane Central, and Google Scholar up to April 2025. Studies assessing interventions for postoperative edema and ecchymosis were included. Study quality was evaluated using the Cochrane Risk of Bias 2 (RoB 2) tool.

Results: Tranexamic acid was the most consistently effective intervention for reducing ecchymosis. Vessel-preserving surgical techniques significantly reduced edema and hematoma, while skin-only excision led to less swelling than combined skin and muscle excision. Carbon dioxide laser - assisted blepharoplasty improved hemostasis and reduced chemosis. Magnesium sulfate dressings were more effective for edema than ice packs, though cold compresses provided short-term relief. Anesthesia modifications (pre-cooling, buffered lidocaine) reduced injection pain but had variable effects on swelling. Herbal and adjunctive therapies, including Arnica montana and bromelain, showed no significant benefits.

Conclusion: Tranexamic acid, vessel-preserving surgical methods, and magnesium sulfate dressings are among the most effective strategies for minimizing ecchymosis and edema in eyelid and periocular surgery. Further RCTs should explore optimized combinations of these interventions and assess long-term patient-reported outcomes.

目的:系统评价旨在减少眼睑和眼周手术术后水肿和瘀斑的循证干预措施,以改善患者的预后和恢复。方法:系统回顾29项随机对照试验(RCTs),涉及2,287例眼睑及眼周手术患者。在Embase, MEDLINE, Cochrane Central和谷歌Scholar上进行了全面的搜索,直到2025年4月。研究评估了术后水肿和瘀斑的干预措施。采用Cochrane风险偏倚2 (RoB 2)工具评价研究质量。结果:氨甲环酸是减少瘀斑最一致有效的干预措施。保留血管的手术技术可显著减少水肿和血肿,而仅皮肤切除比皮肤和肌肉联合切除导致的肿胀更少。二氧化碳激光辅助眼睑成形术改善了止血,减少了化脓。硫酸镁敷料比冰袋对水肿更有效,尽管冷敷可以短期缓解。麻醉修改(预冷、缓冲利多卡因)减轻了注射痛,但对肿胀的影响不同。草药和辅助疗法,包括山金车和菠萝蛋白酶,显示没有显著的好处。结论:氨甲环酸、保留血管的手术方法和硫酸镁敷料是减少眼睑和眼周手术瘀斑和水肿的最有效策略。进一步的随机对照试验应该探索这些干预措施的优化组合,并评估患者报告的长期结果。
{"title":"Interventions for reducing bleeding and swelling in eyelid and periocular surgeries: a systematic review of randomized controlled trials.","authors":"Anas Alamoudi, Asim M Albishry, Ahmed N Alnabihi, Waleed T Batais, Abdulaziz Khalid Aldahlawi, Nawaf F Alghamdi, Mohammad Karam, Christian El-Hadad","doi":"10.1080/01676830.2025.2581622","DOIUrl":"10.1080/01676830.2025.2581622","url":null,"abstract":"<p><strong>Purpose: </strong>To systematically evaluate evidence-based interventions aimed at reducing postoperative edema and ecchymosis in eyelid and periocular surgery, with the goal of improving patient outcomes and recovery.</p><p><strong>Methods: </strong>A systematic review of 29 randomized controlled trials (RCTs), involving 2,287 patients undergoing eyelid and periocular surgery, was conducted. A comprehensive search was performed across Embase, MEDLINE, Cochrane Central, and Google Scholar up to April 2025. Studies assessing interventions for postoperative edema and ecchymosis were included. Study quality was evaluated using the Cochrane Risk of Bias 2 (RoB 2) tool.</p><p><strong>Results: </strong>Tranexamic acid was the most consistently effective intervention for reducing ecchymosis. Vessel-preserving surgical techniques significantly reduced edema and hematoma, while skin-only excision led to less swelling than combined skin and muscle excision. Carbon dioxide laser - assisted blepharoplasty improved hemostasis and reduced chemosis. Magnesium sulfate dressings were more effective for edema than ice packs, though cold compresses provided short-term relief. Anesthesia modifications (pre-cooling, buffered lidocaine) reduced injection pain but had variable effects on swelling. Herbal and adjunctive therapies, including Arnica montana and bromelain, showed no significant benefits.</p><p><strong>Conclusion: </strong>Tranexamic acid, vessel-preserving surgical methods, and magnesium sulfate dressings are among the most effective strategies for minimizing ecchymosis and edema in eyelid and periocular surgery. Further RCTs should explore optimized combinations of these interventions and assess long-term patient-reported outcomes.</p>","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"913-927"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145565593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic angiocentric fibrosis of the lacrimal gland. 泪腺嗜酸性血管中心性纤维化。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-11-27 DOI: 10.1080/01676830.2025.2590190
Jose Gabriel Velasco Stoll, Abelardo Rodríguez-Reyes, Jose Luis Tovilla-Canales, Daniel Benjamin Mejía Llanes, Angel Nava-Castañeda
{"title":"Eosinophilic angiocentric fibrosis of the lacrimal gland.","authors":"Jose Gabriel Velasco Stoll, Abelardo Rodríguez-Reyes, Jose Luis Tovilla-Canales, Daniel Benjamin Mejía Llanes, Angel Nava-Castañeda","doi":"10.1080/01676830.2025.2590190","DOIUrl":"https://doi.org/10.1080/01676830.2025.2590190","url":null,"abstract":"","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"1"},"PeriodicalIF":0.8,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra low dose radiotherapy for primary ocular adnexal marginal zone lymphoma. 超低剂量放疗治疗原发性眼附件边缘区淋巴瘤。
IF 0.8 Q4 OPHTHALMOLOGY Pub Date : 2025-11-21 DOI: 10.1080/01676830.2025.2590205
Gillian A Folk, Marissa K Shoji, Don O Kikkawa
{"title":"Ultra low dose radiotherapy for primary ocular adnexal marginal zone lymphoma.","authors":"Gillian A Folk, Marissa K Shoji, Don O Kikkawa","doi":"10.1080/01676830.2025.2590205","DOIUrl":"https://doi.org/10.1080/01676830.2025.2590205","url":null,"abstract":"","PeriodicalId":47421,"journal":{"name":"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","volume":" ","pages":"1"},"PeriodicalIF":0.8,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145574645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1